Marketed as Actemra, tocilizumab is approved for treating arthritis and other inflammatory conditions.
Credit
Photo courtesy of Roche
Usage Restrictions
Use photo credit
License
Licensed content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.